ArticleImmunology1993
Antibodies to major histocompatibility complex class II inhibit proliferation, but increase production of soluble CD23 in lymphoblastoid B-cell lines.
Article in Immunology, 1993. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed, 2 citations in OpenAlex.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Class II major histocompatibility complex (MHC) proteins bind and present peptide antigens to T cells. Moreover, their function as signal transduction molecules has recently been emphasized. Here we used Epstein-Barr virus (EBV)-transformed B-cell lines (B-LCL) in experiments to investigate the changes induced by binding of specific antibodies to HLA-DR molecules. Binding of the antibodies induced, in an allele-specific manner, striking non-cytotoxic inhibition of B-LCL proliferation. This inhibition was associated with an increase in shedding of soluble CD23. These findings provide further evidence for the function of MHC class II proteins as signal transduction molecules which may be important in B-cell activation.
Indexed as
Identifiers
8307609PMC1422249W2424948769What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.